SAFETY, RESOURCE USE, AND QUALITY OF LIFE (QOL) RESULTS FROM PARAMOUNT: A PHASE III STUDY OF MAINTENANCE PEMETREXED PLUS BEST SUPPORTIVE CARE (BSC) VERSUS PLACEBO PLUS BSC IMMEDIATELY FOLLOWING INDUCTION TREATMENT WITH PEMETREXED-CISPLATIN FOR ADVANCED NONSQUAMOUS NON-SMALL CELL LUNG CANCER (NSCLC)

被引:0
|
作者
Gridelli, Cesare [1 ]
De Marinis, Filippo [2 ]
Pujol, Jean-Louis [3 ]
Reck, Martin [4 ]
Ramlau, Rodryg [5 ]
Parente, Barbara [6 ]
Pieters, Thierry [7 ]
Middleton, Gary [8 ]
Winfree, Katherine [9 ]
Melemed, Symantha [10 ]
Zimmermann, Annamaria H. [10 ]
John, William [10 ]
Beyrer, Julie [9 ]
Chouaki, Nadia [11 ]
Visseren-Grul, Carla
Paz Ares, Luis [12 ]
机构
[1] S Giuseppe Moscati Hosp, Div Med Oncol, Avellino, Italy
[2] High Specializat Hosp, Oncol Pulm Unit 1, Rome, Italy
[3] Montpellier Acad Hosp, Hop Arnaud De Villeneuve, Montpellier, France
[4] Krankenhaus Grosshansdorf, Grosshansdorf, Germany
[5] Poznan Univ Med Sci, Wielkopolskie Ctr Pulmonol Torakochirurg 1, Poznan, Poland
[6] Ctr Hosp Vila Nova De Gaia Espinho Epe, Vila Nova De Gaia, Portugal
[7] Clin Univ St Luc, Woluwe Saint Lambert, Belgium
[8] St Lukes Canc Ctr, Royal Surrey Cty Hosp Nhs Trust, Surrey, England
[9] Eli Lilly & Co, Oncol, Indianapolis, IN USA
[10] Eli Lilly & Co, Indianapolis, IN USA
[11] Eli Lilly & Co, Suresnes, France
[12] Univ Hosp Virgen Del Rocio, Seville, Spain
关键词
Paramount; Pemetrexed; maintenance; Quality of Life;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:S323 / S324
页数:2
相关论文
共 50 条
  • [1] PARAMOUNT: Phase III study of maintenance pemetrexed (pem) plus best supportive care (BSC) versus placebo plus BSC immediately following induction treatment with pem plus cisplatin for advanced nonsquamous non-small cell lung cancer (NSCLC)
    Paz-Ares, L. G.
    De Marinis, F.
    Dediu, M.
    Thomas, M.
    Pujol, J.
    Bidoli, P.
    Molinier, O.
    Sahoo, T. P.
    Laack, E.
    Reck, M.
    Corral, J.
    Melemed, S. A.
    John, W. J.
    Chouaki, N.
    Zimmerman, A.
    Grul, C. M. Visseren
    Gridelli, C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [2] PARAMOUNT: Phase III study of maintenance pemetrexed (pem) plus best supportive care (BSC) versus placebo plus BSC immediately following induction treatment with pem plus cisplatin for advanced nonsquamous non-small cell lung cancer (NSCLC)
    Paz-Ares, L. G.
    De Marinis, F.
    Dediu, M.
    Thomas, M.
    Pujol, J.
    Bidoli, P.
    Molinier, O.
    Sahoo, T. P.
    Laack, E.
    Reck, M.
    Corral, J.
    Melem, S. A.
    Grul, C. M. Visseren
    Gridelli, C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (18)
  • [3] UPDATED SAFETY AND QUALITY OF LIFE (QOL) RESULTS OF PARAMOUNT STUDY: MAINTENANCE PEMETREXED (PEM) PLUS BEST SUPPORTIVE CARE (BSC) VS PLACEBO (PBO) PLUS BSC IMMEDIATELY FOLLOWING INDUCTION TREATMENT WITH PEM PLUS CISPLATIN (CP) FOR ADVANCED NONSQUAMOUS NON-SMALL CELL LUNG CANCER (NS-NSCLC)
    Pujol, J.
    Paz-Ares, L.
    Dediu, M.
    Thomas, M.
    Bidoli, P.
    Corral, J.
    Chouaki, N.
    Visseren-Grul, C. M.
    Zimmermann, A.
    Gridelli, C.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 418 - 419
  • [4] Overall survival (OS) of maintenance pemetrexed (pem) plus best supportive care (BSC) versus placebo plus BSC immediately following induction treatment with pem plus cisplatin for advanced nonsquamous non-small cell lung cancer (NSCLC): final results of a phase Ill study (PARAMOUNT)
    Laack, E.
    Reck, M.
    Schumann, C.
    Eschbach, C.
    Kimmich, M.
    Brandts, C.
    Paz-Ares, L. G.
    De Marinis, F.
    Dediu, M.
    Pujol, J.-L.
    Bidoli, P.
    Molinier, O.
    Sahoo, T. P.
    Corral, J.
    Melemed, S. A.
    John, W. J.
    Chouaki, N.
    Zimmermann, A. H.
    Visseren-Grul, C. M.
    Leschinger, M., I
    Thomas, M.
    [J]. ONKOLOGIE, 2012, 35 : 36 - 37
  • [5] PARAMOUNT: Final overall survival (OS) results of the phase III study of maintenance pemetrexed (pem) plus best supportive care (BSC) versus placebo (plb) plus BSC immediately following induction treatment with pem plus cisplatin (cis) for advanced nonsquamous (NS) non-small cell lung cancer (NSCLC).
    Paz-Ares, Luis
    De Marinis, Filippo
    Dediu, Mircea
    Thomas, Michael
    Pujol, Jean-Louis
    Bidoli, Paolo
    Molinier, Oliver
    Sahoo, Tarini Prasad
    Laack, Eckart
    Reck, Martin
    Jaime, Jesus Corral
    Melemed, Symantha
    John, William J.
    Chouaki, Nadia
    Zimmermann, Annamaria
    Visseren-Grul, Carla
    Gridelli, Cesare
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [6] MAINTENANCE PEMETREXED (PEM) PLUS BEST SUPPORTIVE CARE (BSC) VERSUS PLACEBO PLUS BSC AFTER PEM PLUS CISPLATIN FOR ADVANCED NONSQUAMOUS NSCLC
    Obasaju, C. K.
    Paz-Ares, L. G.
    De Marinis, F.
    Dediu, M.
    Thomas, M.
    Pujol, J. L.
    Bidoli, P.
    Molinier, O.
    Sahoo, T. P.
    Laack, E.
    Reck, M.
    Corral, J.
    Melemed, S. A.
    John, W. J.
    Chouaki, N.
    Zimmermann, A.
    Visseren-Grul, C. M.
    Gridelli, C.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 8 - 8
  • [7] Maintenance pemetrexed (Pem) plus best supportive care (BSC) versus placebo (Plac) plus BSC: A randomized phase III study in advanced non-small cell lung cancer (NSCLC)
    Belani, C. P.
    Brodowicz, T.
    Ciuleanu, T.
    Kim, J. H.
    Krzakowski, M.
    Laack, E.
    Wu, Y. L.
    Peterson, P.
    Krejcy, K.
    Zielinski, C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (18)
  • [8] Maintenance pemetrexed (Pem) plus best supportive care (BSC) versus placebo (Plac) plus BSC: A randomized phase III study in advanced non-small cell lung cancer (NSCLC)
    Belani, C. P.
    Brodowicz, T.
    Ciuleanu, T.
    Kim, J. H.
    Krzakowski, M.
    Laack, E.
    Wu, Y. L.
    Peterson, P.
    Krejcy, K.
    Zielinski, C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [9] Maintenance pemetrexed plus best supportive care (BSC) versus placebo plus BSC: A phase III study
    Ciuleanu, T. E.
    Brodowicz, T.
    Belani, C. P.
    Kim, J.
    Krzakowski, M.
    Laack, E.
    Wu, Y.
    Peterson, P.
    Adachi, S.
    Zielinski, C. C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [10] Safety, Resource Use, and Quality of Life in PARAMOUNT A Phase III Study of Maintenance Pemetrexed Versus Placebo after Induction Pemetrexed Plus Cisplatin for Advanced Nonsquamous Non-Small-Cell Lung Cancer
    Gridelli, Cesare
    de Marinis, Filippo
    Pujol, Jean-Louis
    Reck, Martin
    Ramlau, Rodryg
    Parente, Barbara
    Pieters, Thierry
    Middleton, Gary
    Corral, Jesus
    Winfree, Katherine
    Melemed, Symantha
    Zimmermann, Anna
    John, William
    Beyrer, Julie
    Chouaki, Nadia
    Visseren-Grul, Carla
    Paz-Ares, Luis G.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (11) : 1713 - 1721